These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 14818315

  • 1. [Serum sickness following injection of tetanus antitoxin as an unusual cause of cardiac infarct with eosinophil myocarditis].
    HEINTZ R.
    Z Kreislaufforsch; 1951 Jan; 40(1-2):40-3. PubMed ID: 14818315
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasmocytosis in serum sickness from tetanus antitoxin; report of case.
    CARNIG P, HEDRICK E.
    Am J Clin Pathol; 1954 Jul; 24(7):802-6. PubMed ID: 13171350
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum sickness.
    WHITFIELD M.
    Br Med J; 1953 Jan 17; 1(4802):141. PubMed ID: 13009113
    [No Abstract] [Full Text] [Related]

  • 8. [Anaphylactic shock following administration of Fermo-tetanus antitoxin as a tolerance test].
    KRAUSE E.
    Monatsschr Unfallheilkd Versicherungsmed; 1960 Sep 17; 63():352-4. PubMed ID: 13754080
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antihistamine in the prevention of serum reaction following injection of tetanus antitoxin.
    WAXMAN A, GESHELIN H.
    Calif Med; 1951 Aug 17; 75(2):93. PubMed ID: 14848728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CURRENT STATUS OF TETANUS CONTROL. IMPORTANCE OF HUMAN TETANUS-IMMUNE GLOBULIN.
    SKUDDER PA, MCCARROLL JR.
    JAMA; 1964 May 18; 188():625-7. PubMed ID: 14121281
    [No Abstract] [Full Text] [Related]

  • 14. TETANUS PROPHYLAXIS.
    COX CA, KNOWELDEN J, SHARRARD WJ.
    Br Med J; 1963 Nov 30; 2(5369):1360-6. PubMed ID: 14063025
    [No Abstract] [Full Text] [Related]

  • 15. MYOCARDIAL INFARCTION AFTER SERUM SICKNESS FROM TETANUS ANTITOXIN.
    CATALANO TC.
    JAMA; 1964 Jun 29; 188():1154-6. PubMed ID: 14163117
    [No Abstract] [Full Text] [Related]

  • 16. [Myocardial infarct as an unusual complication of tetanus antitoxin].
    Czirner J, Besznyák G.
    Orv Hetil; 1967 Dec 17; 108(51):2423-4. PubMed ID: 5594670
    [No Abstract] [Full Text] [Related]

  • 17. A RE-EVALUATION OF TETANUS PROPHYLAXIS IN CIVILIAN PRACTICE.
    RUBBO SD.
    Med J Aust; 1965 Jul 17; 2(3):105-9. PubMed ID: 14333766
    [No Abstract] [Full Text] [Related]

  • 18. [Serum sickness following tetanus anti-toxin injection with concomitant formation of specific blood group immune-antibodies].
    HOLLANDER L, WORTMANN F.
    Praxis; 1952 Nov 27; 41(48):1047-8. PubMed ID: 13026749
    [No Abstract] [Full Text] [Related]

  • 19. THE PROBLEM OF TETANUS PROPHYLAXIS.
    BOURKE GJ.
    J Ir Med Assoc; 1964 Sep 27; 55():56-63. PubMed ID: 14175967
    [No Abstract] [Full Text] [Related]

  • 20. MYOSITIS OSSIFICANS AS A COMPLICATION OF TETANUS.
    PITTS NC.
    JAMA; 1964 Jul 20; 189():237-9. PubMed ID: 14150012
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.